Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Implementation of G6PD testing: challenges and opportunities | APMEN TechTalks

Malaria Elimination in Asia Pacific
926 subscribers
<__slot-el>
<__slot-el>
These chapters are auto-generated

Intro

0:00

Implementation of G6PD testing: challenges and opportunities

0:43

G6PD deficiency (G6PDd)

2:29

Plasmodium vivax

3:37

G6PDd and malaria

4:50

Current cut-offs & diagnostics

5:27

Haemolysis in a population

7:16

Haemolysis in heterozygotes

8:13

Haemolysis after overdosing

9:21

Why is G6PD testing not done?

10:16

Types of G6PD diagnostics 1. Quantitative

12:18

Quantitative Test 1. Spectrophotometric Randox

14:51

SD Biosensor vs Pointe Scientific

17:07

Qualitative Test

18:36

FST vs Carestart RDT

20:54

Qualitative and quantitative G6PD revisited

24:11

Qualitative G6PD test: gaps in current supply

26:23

Products in the pipeline to support qualitative G6PD testing

28:56

(Semi)-quantitative G6PD test: gaps in current supply

30:22

Products in the pipeline to support quantitative G6PD testing

33:09

Malaria in Bangladesh

37:38

Study objectives

37:57

Study design (Oct/Nov 2019)

39:05

Complications of the context of elimination

41:31

Considerations for introducing the Biosensor into routine practice

45:16

Conclusions & Future work

48:19

Study limitations & future work

49:30
Implementation of G6PD testing: challenges and opportunities | APMEN TechTalks
6Likes
396Views
2020Sep 24
APMEN TechTalks - 24 September 2020 Speakers
  • Dr. Benedikt Ley, APMEN Vivax Working Group, Menzies School of Health Research, Australia
  • Dr. Ari Winasti Satyagraha, Eijkman Institute of Molecular Biology, Indonesia
  • Dr. Gonzalo Domingo, PATH, USA
  • Cristian Ghergu, Maastricht University, Netherlands
Panel Members
  • Dr. Kinley Penjor, Ministry of Health, Bhutan
  • Dr. Moses Laman, Papua New Guinea Institute of Medical Research
  • Dr. Anupkumar Anvikar, ICMR-National Institute of Malaria Research, India
Moderators
  • Dr. Benedikt Ley, APMEN Vivax Working Group, Menzies School of Health Research, Australia
  • Dr. Rosalind Howes, Foundation for Innovative Diagnostics, Switzerland

Follow along using the transcript.

Malaria Elimination in Asia Pacific

926 subscribers